Products

Human HLA-A*02:01&B2M&MART-1 Monomer, E. coli

Overview Specification

Product Name	Human HLA-A*02:01&B2M&MART-1 Monomer, E. coli
Cat. No.	MHCRP-0519
Category	Proteins & Peptides
Product Description	Recombinant Human HLA-A02:01&B2M&MART-1 (EAAGIGILTV) Monomer Protein is expressed from E. coli* with His tag and Avi tag at the C-terminus. It contains Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and EAAGIGILTV peptide.
Size	100/500 μg
Format	Liquid. Supplied as 0.22 μm filtered solution in 20 mM Tris, 200 mM NaCl (pH 8.0).
Storage	Store at -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Shipping Temp	Shipped with dry ice.
Lead Time	Product delivery time depends on the supplier.
Species	Human
Expression Host	E. coli
Accession No	A0A140T913(HLA-A*02:01)&P61769(B2M)&EAAGIGILTV
Tag	C-His-Avi
Tag Position	C-terminus
Molecular Type	Monomer
Molecular Weight (MV)	The protein has a predicted MW of 35.6 kDa (HLA-A*02:01) and 11.9 kDa (B2M) same as Bis-Tris PAGE result.
Gene Synonyms	MART1; LB39-AA; SK29-AA; Melan-A; MLANA
Purity	> 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC.
Amino Acid Range	Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M), and EAAGIGILTV peptide
Activity	Immobilized human HLA-A*02:01&B2M&MART-1 (EAAGIGILTV) monomer, His tag at 0.5 μg/mL (100 μL/well) on the plate. Dose response curve for anti-B2M antibody, mFc tag with the EC50 of 10.1 ng/mL determined by ELISA.
Product Background	Melanoma antigen recognized by T cell-1 (Mart-1), one of the melanosome-specific proteins, also recognized by cytotoxicity T lymphocytes as a marker. Mart-1 is considered to play a critical role in the immunotherapy for melanoma.
Allele	HLA-A*02:01
Biotinylated	No

For research or industrial raw materials, not for personal medical use!